- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07296068
Czy ostra fotobiomodulacja może poprawić równowagę i funkcje poznawcze u osób z ataksją: pilotażowe, wykonalnościowe, randomizowane, kontrolowane badanie z użyciem placebo.
Czy ostra fotobiomodulacja może poprawić równowagę i funkcje poznawcze u osób z ataksją: pilotażowe, randomizowane, kontrolowane placebo badanie wykonalności.
Cerebellar ataxias cause progressive impairments in balance, gait coordination, motor timing, and cognitive functions such as attention and executive control (Buckner, 2013; Salmi et al., 2010; Timmann & Daum, 2007). These symptoms substantially reduce independence and quality of life, and current treatments remain limited. There is an urgent need for safe, low-burden interventions that can support everyday functioning and potentially enhance compensatory neural processes.
Transcranial photobiomodulation (tPBM) uses red and near-infrared light (600-1100 nm) to modulate mitochondrial cytochrome-c oxidase, increasing ATP production, reducing oxidative stress, and improving cerebral blood flow (Hamblin, 2016; Salehpour et al., 2019). Several studies show that tPBM can acutely improve cognitive performance and motor control in both healthy adults and clinical groups (Barrett & Gonzalez-Lima, 2013; Chan et al., 2019; Henderson & Morries, 2017). A growing neurobiological literature suggests that light can penetrate posterior cortical areas sufficiently to modulate networks involving cerebellar-cortical loops (Jagdeo et al., 2012).
Importantly for ataxia, preliminary work shows that tPBM may acutely improve balance stability and gait metrics in older adults and patients with neurological conditions (Moro et al., 2022; Shin et al., 2021). In our own laboratory, we have observed immediate improvements in sway range and cognitive control in older adults after a 24-minute tPBM session applied over midline and posterior scalp regions. These medium to large size effects are consistent with enhanced sensorimotor integration and improved control of attention in distracting environments.
Given that individuals with cerebellar ataxia experience both motor incoordination and difficulties in maintaining cognitive stability under distracting conditions, tPBM is a promising non-pharmacological intervention worth preliminary investigation.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Jonathan J Sinclair, DSc
- Numer telefonu: +44787565153
- E-mail: jksinclair@lancashire.ac.uk
Lokalizacje studiów
-
-
Lancashire
-
Preston, Lancashire, Zjednoczone Królestwo, PR1 2HE
- University of Central Lancashire
-
Kontakt:
- Sinclair
- Numer telefonu: 07875651533
- E-mail: jksinclair@lancashire.ac.uk
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Age 18-70 years (inclusive)
- Diagnosis of ataxia
- Able to walk independently for at least 5 minutes, with or without an assistive device
- Able to stand safely for balance testing, with or without an assistive device
- Hemodynamically stable (stable blood pressure and heart rate at rest)
- On a stable medication regimen for ≥4 weeks prior to enrolment
- Sufficient vision and hearing (with usual aids if required) to complete balance and cognitive assessments
- Able to complete study questionnaires and cognitive tasks (with assistance for reading/writing if required)
- Able and willing to provide written informed consent
Exclusion Criteria:
- Current or past history of head injury
- Use of medications acting on the central nervous system
- Active skin conditions on the forehead or scalp
- Any other major neurological disorder that could independently affect balance or cognition
- Ongoing brain stimulation therapy
- History of migraines
- Sensitive skin, allergies
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Komparator placebo: Sham Comparator: Sham photobiomodulation
Sham photobiomodulation. The sham device will follow the same protocol but without active light emission. |
The sham device will follow the same protocol but without active light emission. |
|
Eksperymentalny: Photobiomodulation
Acute photobiomodulation Twenty-four-minute photobiomodulation stimulation (twelve minutes at 670 nm followed by twelve minutes at 810 nm). |
Photobiomodulation |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
n-1-back (deviation)
Ramy czasowe: Baseline
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
Baseline
|
|
n-1-back (deviation)
Ramy czasowe: 1 hour
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier. |
1 hour
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
n-2-back (deviation)
Ramy czasowe: Baseline
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
Baseline
|
|
n-2-back (deviation)
Ramy czasowe: 1 hour
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-deviation)
Ramy czasowe: Baseline
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-deviation)
Ramy czasowe: 1 hour
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-deviation)
Ramy czasowe: Baseline
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-deviation)
Ramy czasowe: 1 hour
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (post-target)
Ramy czasowe: Baseline
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
Baseline
|
|
n-1-back (post-target)
Ramy czasowe: 1 hour
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier. |
1 hour
|
|
n-2-back (post-target)
Ramy czasowe: Baseline
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
Baseline
|
|
n-2-back (post-target)
Ramy czasowe: 1 hour
|
The n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier. |
1 hour
|
|
n-1-back (load)
Ramy czasowe: Baseline
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
Baseline
|
|
n-1-back (load)
Ramy czasowe: 1 hour
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back. |
1 hour
|
|
n-2-back (post-load)
Ramy czasowe: Baseline
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
Baseline
|
|
n-2-back (post-load)
Ramy czasowe: 1 hour
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task. |
1 hour
|
|
Coop-Wonka chart
Ramy czasowe: Baseline
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
Baseline
|
|
Coop-Wonka chart
Ramy czasowe: 1 hour
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing. |
1 hour
|
|
Beck Depression Inventory
Ramy czasowe: Baseline
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
Baseline
|
|
Beck Depression Inventory
Ramy czasowe: 1 hour
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible. |
1 hour
|
|
Pittsburgh Sleep Quality Index
Ramy czasowe: Baseline
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
Baseline
|
|
Pittsburgh Sleep Quality Index
Ramy czasowe: 1 hour
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality. |
1 hour
|
|
State Trait Anxiety Inventory
Ramy czasowe: Baseline
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
Baseline
|
|
State Trait Anxiety Inventory
Ramy czasowe: 1 hour
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety. |
1 hour
|
|
Insomnia Severity Index
Ramy czasowe: Baseline
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
Baseline
|
|
Insomnia Severity Index
Ramy czasowe: 1 hour
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28. |
1 hour
|
|
Epworth Sleepiness Scale
Ramy czasowe: Baseline
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
Baseline
|
|
Epworth Sleepiness Scale
Ramy czasowe: 1 hour
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24. |
1 hour
|
|
Everyday Memory Errors Questionnaire
Ramy czasowe: Baseline
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
Baseline
|
|
Everyday Memory Errors Questionnaire
Ramy czasowe: 1 hour
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties. |
1 hour
|
|
Falls Efficacy
Ramy czasowe: Baseline
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
Baseline
|
|
Falls Efficacy
Ramy czasowe: 1 hour
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy. |
1 hour
|
|
Anterior-posterior balance
Ramy czasowe: Baseline
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Anterior-posterior balance
Ramy czasowe: 1 hour
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
|
Medio-lateral balance
Ramy czasowe: Baseline
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
Baseline
|
|
Medio-lateral balance
Ramy czasowe: 1 hour
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task. |
1 hour
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- PMB Ataxia pilot feasibility s
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .